Drug Shortage Report for PROQUAD

Last updated on 2019-09-19 History
Report ID 90641
Drug Identification Number 02399229
Brand name PROQUAD
Common or Proper name measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 10X1DOSE VIAL
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-01
Actual start date
Estimated end date 2019-11-29
Actual end date 2019-09-19
Shortage status Avoided shortage
Updated date 2019-09-19
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-09-19 English Compare
v5 2019-08-02 French Compare
v4 2019-08-02 English Compare
v3 2019-08-02 French Compare
v2 2019-08-02 English Compare
v1 2019-08-02 English Compare